AKT1 and neoplasm: Another study using carcinoma cells showed that perturbation of HA-CD44 binding leads to suppression of the phosphoinositide 3-kinase (PI3K)/Akt pathway, thereby inhibiting cell and tumour growth (Ghatak et al, 2002).